The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth. [electronic resource]
Producer: 20180105Description: 37103-37120 p. digitalISSN:- 1949-2553
- Aminopyridines -- pharmacology
- Animals
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Membrane -- drug effects
- Cell Transformation, Neoplastic -- drug effects
- Choline -- metabolism
- Choline Kinase -- antagonists & inhibitors
- Citrate (si)-Synthase -- metabolism
- Endoplasmic Reticulum Stress -- drug effects
- Female
- Fluorescent Antibody Technique
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Humans
- Metabolomics
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mitochondria -- drug effects
- Phosphatidylcholines -- metabolism
- Positron-Emission Tomography
- Protein Kinase Inhibitors -- pharmacology
- Pyridinium Compounds -- pharmacology
- Reactive Oxygen Species -- metabolism
- Signal Transduction -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.